ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 584,00
-0,64%
Dow Jones
40 211,72
0,00%
DAX
18 512,13
-0,47%
Brent Oil
82,895
-1,71%
Bitcoin
63 929,84
-1,42%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Allos Therapeutics, Inc. (MM) (ALTH)

  7. Allos Therapeutics, Inc. (MM) (ALTH) Actualités

ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ALTH
DateHeureSourceTitreSymboleSociété
16/04/201212h04Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
13/04/201223h24Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
13/04/201223h11Edgar (US Regulatory)Amended Annual Statement of Changes in Beneficial Ownership (5/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
09/04/201217h26Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
09/04/201214h15ZacksAllos Eyed by Spectrum Pharma - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
09/04/201211h06ZacksCompany News for April 9, 2012 - Corporate SummaryNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
06/04/201212h07Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
06/04/201212h06Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/04/201223h23Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/04/201220h07Dow Jones NewsUPDATE: Amid Setback, Spectrum Pharma To Buy Allos For $206 MillionNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/04/201216h28PR Newswire (US)Allos Therapeutics, Inc. (ALTH) Shareholder Alert: Bernstein Liebhard LLP Announces Investigation of Acquisition By Spectrum ...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/04/201214h52PR Newswire (US)Block & Leviton LLP Investigates Allos Therapeutics, Inc. for Possible Breaches of Fiduciary Duties for Its Proposed Merger w...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/04/201213h00Business WireSpectrum Pharmaceuticals to Acquire Allos Therapeutics: Acquisition Expected to Be Accretive on a Cash Basis in Q4 of 2012NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/03/201210h14ZacksZacks #1 Rank Additions for Friday - Tale of the TapeNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
26/03/201212h03Edgar (US Regulatory)Amended Quarterly Report (10-Q/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
22/03/201211h00ZacksAllos Upped to Outperform - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/03/201209h15ZacksAllos Narrows Loss - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
06/03/201222h00Business WireAllos Therapeutics Reports Fourth Quarter and Full Year 2011 Financial ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
02/03/201200h18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
27/02/201223h48Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
24/02/201200h19Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
21/02/201214h00Business WireAllos Therapeutics to Report Fourth Quarter and Full Year 2011 Results on March 6, 2012NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
14/02/201221h33Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
14/02/201216h43Edgar (US Regulatory)Schedule 13GNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
10/02/201216h59Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
06/02/201218h46ZacksALTH Seeks Review of Folotyn Verdict - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/01/201214h30Business WireAllos Therapeutics Requests Re-Examination of CHMP Opinion on FOLOTYN® in PTCL at the European Medicines AgencyNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/01/201214h00Business WireAllos Therapeutics Announces Interim Results from Phase 1 Combination Study of FOLOTYN® & Bexarotene Demonstrate Activity in...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/01/201213h00ZacksEuropean Setback for Allos - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/01/201213h43Business WireAllos Therapeutics Receives Negative Opinion from the CHMP on FOLOTYNNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ALTH

Dernières Valeurs Consultées

NASDAQ
STRT
Strattec Security
LSE
SBIO
Inv Nas Biotech
LSE
AT1
Ivz At1 Capbond
USOTC
TSCDY
Tesco (PK)
LSE
UC14
Ubsetf Ccusas
NYSE
TIER
Tier Reit Inc.
LSE
0OKE
Medicon Hellas
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés